References - Homocysteine in Protein Structure/Function and Human Disease - page 139

159. Sprince H, Parker CM, Josephs Jr JA, Magazino J. Convulsant activity of homocysteine and
other short-chain mercaptoacids: protection therefrom. Ann N Y Acad Sci. 1969;166
(1):323-5.
160. Greene ND, Dunlevy LE, Copp AJ. Homocysteine is embryotoxic but does not cause neural
tube defects in mouse embryos. Anat Embryol (Berl). 2003;206(3):185-91.
161. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and
glutathione has a protective effect. J Mol Endocrinol. 2001;27(1):85-91.
162. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin-stimulated DNA
and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen
synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol. 2005;34
(1):119-26.
163. Li Y, Jiang C, Xu G, Wang N, Zhu Y, Tang C, et al. Homocysteine upregulates resistin
production from adipocytes in vivo and in vitro. Diabetes. 2008;57(4):817-27.
164. Mercie P, Garnier O, Lascoste L, Renard M, Closse C, Durrieu F, et al. Homocysteine-
thiolactone induces caspase-independent vascular endothelial cell death with apoptotic
features. Apoptosis. 2000;5(5):403-11.
165. Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ. Homocysteine thiolactone induces apoptotic
DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation
in HL-60 cells. Life Sci. 2001;68(25):2799-811.
166. Kamudhamas A, Pang L, Smith SD, Sadovsky Y, Nelson DM. Homocysteine thiolactone
induces apoptosis in cultured human trophoblasts: a mechanism for homocysteine-mediated
placental dysfunction? Am J Obstet Gynecol. 2004;191(2):563-71.
167. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced
vascular endothelial cell activator. J Clin Invest. 1986;77(6):1909-16.
168. Yang X, Gao Y, Zhou J, Zhen Y, Yang Y, Wang J, et al. Plasma homocysteine thiolactone
adducts associated with risk of coronary heart disease. Clin Chim Acta. 2006;364
(1-2):230-4.
169. Capasso R, Sambri I, Cimmino A, Salemme S, Lombardi C, Acanfora F, et al.
Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and
up-regulation of MCP1, Hsp60 and ADAM17. PLoS One. 2012;7(2):e31388.
170. Ferretti G, Bacchetti T, Moroni C, Vignini A, Nanetti L, Curatola G. Effect of homocystei-
nylation of low density lipoproteins on lipid peroxidation of human endothelial cells. J Cell
Biochem. 2004;92(2):351-60.
171. Paoli P, Sbrana F, Tiribilli B, Caselli A, Pantera B, Cirri P, et al. Protein N-homocystei-
nylation induces the formation of toxic amyloid-like protofibrils. J Mol Biol. 2010;400
(4):889-907.
172. Undas A, Perla J, Lacinski M, Trzeciak W, Kazmierski R, Jakubowski H. Autoantibodies
against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke.
2004;35(6):1299-304.
173. Undas A, Stepien E, Glowacki R, Tisonczyk J, Tracz W, Jakubowski H. Folic acid adminis-
tration and antibodies against homocysteinylated proteins in subjects with hyperhomocys-
teinemia. Thromb Haemost. 2006;96(3):342-7.
174. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H. Plasma homocys-
teine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler
Thromb Vasc Biol. 2006;26(6):1397-404.
175. Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M. Modification of
fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential
mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry. 2006;45
(8):2480-7.
176. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, et al. Inhibition of growth and
p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol
Chem. 1997;272(40):25380-5.